SSSW(SH:688399)2023-04-26 16:00Financial Performance - The company's operating revenue for Q1 2023 was ¥94,053,695.57, representing a decrease of 93.82% compared to the same period last year[2] - The net profit attributable to shareholders was -¥19,424,028.96, a decline of 103.08% year-over-year[2] - Basic and diluted earnings per share were both -¥0.33, reflecting a decrease of 103.06%[2] - Total revenue for Q1 2023 was CNY 94,053,695.57, a significant decrease of 93.83% compared to CNY 1,521,902,378.62 in Q1 2022[15] - Net profit for Q1 2023 was a loss of CNY 19,424,028.96, compared to a profit of CNY 631,070,096.78 in Q1 2022, indicating a decline of 103.08%[16] Cash Flow - The net cash flow from operating activities was -¥226,392,877.94, down 146.17% from the previous year[2] - In Q1 2023, the net cash flow from operating activities was -226,392,877.94, a significant decline compared to 490,379,975.90 in Q1 2022[19] - The total cash outflow from operating activities was 497,068,809.17, compared to 866,900,896.52 in the same quarter last year[19] - Cash inflow from sales and services received was 214,177,789.24, a decrease from 1,334,170,582.58 in Q1 2022[18] - The total cash and cash equivalents at the end of Q1 2023 were 979,636,103.79, down from 1,062,017,901.88 at the end of Q1 2022[19] Assets and Liabilities - Total assets at the end of the reporting period were ¥4,715,437,080.57, a decrease of 3.59% from the end of the previous year[3] - Total liabilities as of Q1 2023 amounted to CNY 956,710,813.88, down from CNY 1,112,849,694.21 in the previous year, a reduction of 14.06%[15] - The equity attributable to shareholders was ¥3,758,726,266.69, down 0.51% compared to the previous year[3] - The company's total assets as of March 31, 2023, were ¥4,715,437,080.57, down from ¥4,890,999,989.86, representing a decrease of approximately 3.6%[13] Research and Development - Research and development expenses totaled ¥34,288,082.49, which is an increase of 26.29% year-over-year, accounting for 36.46% of operating revenue, up 34.68 percentage points[2] - Research and development expenses for Q1 2023 were CNY 34,288,082.49, an increase of 26.00% compared to CNY 27,149,529.76 in Q1 2022[16] Investment Activities - Total cash inflow from investment activities reached 2,114,275,580.39, up from 517,215,844.18 in the same period last year[19] - The cash outflow from investment activities was 2,324,226,649.49, compared to 619,363,626.32 in Q1 2022, resulting in a net cash flow from investment activities of -209,951,069.10[19] Shareholder Information - The company has a total of 15,600,000 shares held by its largest shareholder, accounting for 26.61% of the total shares[10] Other Information - The significant decline in revenue was primarily due to a sharp decrease in income from COVID-related products and services[6] - The company has not disclosed any significant new strategies or product developments during the reporting period[11] - The company has not disclosed any new product developments or market expansion strategies in the provided financial report[17]